Repaglinide Rivopharm 0.5 mg, compresse - 90 Swissmedic Key 61234016 Registration Holder Rivopharm SA Name Repaglinide Rivopharm 0.5 mg, compresse Date of registration 24.05.2011 Original/Generic Generic Introduction of Sequence 24.05.2011 ATC-Classification Repaglinide (A10BX02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 90 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 8.39 Limitation Yes Limitation text
Deductible 10 % Consumer price 25.55 Feedback FB Daily cost GTIN 7680612340164 Medication Code Synthetika Pharmacode Disponibility
Composition repaglinidum 0.5 mg, polacrilinum kalicum, megluminum, cellulosum microcristallinum, maydis amylum, povidonum K 90, glycerolum, poloxamerum, calcii hydrogenophosphas, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Repaglinide 0.5 mg
BAG: Active Agent Dose Repaglinide 0.5 mg
Inactive agents Dose Calcium Hydrogen Phosphate Cellulosum Microcristallinum Glycerol Magnesii Stearas Maydis Amylum Meglumine Polacrilinum Kalicum Poloxamer Povidonum K 90 Pro Compresso
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
